SOURCE: annual_report_text (1).txt
CHUNK: 228 of 1106
SIZE: 605 characters
PREVIOUS: chunk_0227_annual_report_text (1).txt
NEXT: chunk_0229_annual_report_text (1).txt
------------------------------
d be 
developed. The development and marketing of technology 
resulting in novel therapies do nevertheless 
require a relatively long period of time. Reimbursement of healthcare 
The subsidization by healthcare reimbursement 
institutions of costs for the treatment of certain 
diseases for which equipment made by IBA is 
directly or indirectly involved is continuously 
under scrutiny. The healthcare reimbursement 
policies of these organizations will in turn 
influence the volume of orders that IBA obtains. These subsidies from reimbursement institutions 
differ greatly from one country to another.